BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29255356)

  • 21. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of thyroxine-binding globulin as a candidate plasma marker of chronic obstructive pulmonary disease.
    Diao W; Shen N; Du Y; Sun X; Liu B; Xu M; He B
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1549-1564. PubMed ID: 28579773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annual decline in arterial blood oxygen predicts development of chronic respiratory failure in COPD with mild hypoxaemia: A 6-year follow-up study.
    Uemasu K; Sato S; Muro S; Sato A; Tanabe N; Hasegawa K; Hamakawa Y; Mizutani T; Fuseya Y; Tanimura K; Takahashi T; Hirai T
    Respirology; 2019 Mar; 24(3):262-269. PubMed ID: 30230650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective cohort study.
    Inaguma D; Koide S; Ito E; Takahashi K; Hayashi H; Hasegawa M; Yuzawa Y;
    Clin Exp Nephrol; 2018 Apr; 22(2):353-364. PubMed ID: 28766029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C reactive protein and long-term risk for chronic kidney disease: a historical prospective study.
    Kugler E; Cohen E; Goldberg E; Nardi Y; Levi A; Krause I; Garty M; Krause I
    J Nephrol; 2015 Jun; 28(3):321-7. PubMed ID: 24981713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient impact of automated glomerular filtration rate reporting on drug dosing for hospitalized older adults with concealed renal insufficiency.
    Kalender-Rich JL; Mahnken JD; Wetmore JB; Rigler SK
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):320-7. PubMed ID: 21920825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concealed renal failure and adverse drug reactions in older patients with type 2 diabetes mellitus.
    Corsonello A; Pedone C; Corica F; Mazzei B; Di Iorio A; Carbonin P; Incalzi RA;
    J Gerontol A Biol Sci Med Sci; 2005 Sep; 60(9):1147-51. PubMed ID: 16183954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.
    Schei J; Stefansson VT; Mathisen UD; Eriksen BO; Solbu MD; Jenssen TG; Melsom T
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):280-6. PubMed ID: 26668020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of novel cytokines in inflammation: Defining peripheral artery disease among patients with coronary artery disease.
    Ozkaramanli Gur D; Guzel S; Akyuz A; Alpsoy S; Guler N
    Vasc Med; 2018 Oct; 23(5):428-436. PubMed ID: 29638194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystatin C is Better than Serum Creatinine for Estimating Glomerular Filtration Rate to Detect Osteopenia in Chronic Kidney Disease Patients.
    Kwon YE; Lee MJ; Park KS; Han SH; Yoo TH; Oh KH; Lee J; Lee KB; Chung W; Kim YH; Ahn C; Choi KH
    Yonsei Med J; 2017 Mar; 58(2):380-387. PubMed ID: 28120569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV
    Wang Y; Liao J; Zhong Y; Zhang C; Li X; Wang G
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2825-2833. PubMed ID: 31824147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects.
    Miyakoshi T; Nakasone Y; Sato Y; Yamauchi K; Hashikura R; Takayama M; Hirabayashi K; Koike H; Moriya T; Aizawa T
    Nephrology (Carlton); 2017 Sep; 22(9):684-689. PubMed ID: 27282755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation.
    Jo YS; Yoon HI; Kim DK; Yoo CG; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():101-107. PubMed ID: 29317814
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Grdić Rajković M; Popović-Grle S; Vukić Dugac A; Rogić D; Rako I; Radić Antolić M; Beriša M; Rumora L
    J Clin Pathol; 2018 Nov; 71(11):963-970. PubMed ID: 29858231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of clinical characteristics to predict spirometric classification of obstructive lung disease.
    Pascoe SJ; Wu W; Collison KA; Nelsen LM; Wurst KE; Lee LA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():889-902. PubMed ID: 29559773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
    Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COPD assessment test score and serum C-reactive protein levels in stable COPD patients.
    Kang HK; Kim K; Lee H; Jeong BH; Koh WJ; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3137-3143. PubMed ID: 27994452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
    Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.